Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Older adults with multiple myeloma face heavy burden of care

Publish date:: October 8, 2020

Key clinical point: Decision making for elder patients with MM should include a discussion of the burden of care, not just possible outcomes.

Major finding: There is substantial burden of treatment, with over 2 months of cumulative interaction with health care in the first year.

Study details: The treatment burden among 3,065 newly diagnosed adults with MM was retrospectively analyzed.

Disclosures: The study was funded by the National Cancer Institute at the U.S. National Institutes of Health. The authors reported funding from a variety of pharmaceutical and biotechnology companies.

Citation:

Mian HS et al. Clin Lymphoma Myeloma Leuk. 2020 Oct 1. doi: 10.1016/j.clml.2020.09.010.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Geriatrics

Study links sleep meds and dementia risk in older adults,

Mortality higher in older adults hospitalized for IBD,

Sedentary postmenopausal women have higher heart failure risk,

Older adults with multiple myeloma face heavy burden of care,

NSAID continuation linked to less knee OA pain,